OPTOMED OYJ |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.11 EUR | +3.01% |
|
-0.84% | +10.63% |
| Feb. 15 | Transcript : Optomed Oyj, 2023 Earnings Call, Feb 15, 2024 | |
| Feb. 15 | Optomed Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presenter SpeechSakari Knuutti (Executives)All right. Good morning. Welcome to Optomed Q3 Inve...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.11
EUR
Average target price
5.8
EUR
Spread / Average Target
+41.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.63% | 78M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- OPTOMED Stock
- News Optomed Oyj
- Transcript : Optomed Oyj, Q3 2022 Earnings Call, Nov 03, 2022
